Hawkins
HWKN Nasdaq Commodity Chemicals Financials FY2017βFY2026
Hawkins' revenue rose 11.2% to $1.1 billion in fiscal 2026. Its operating margin was 11.2%, down from 12.2% a year earlier. Free cash flow was $86 million, up 23.0%. It paid out $16 million in dividends and buybacks, 18% of free cash flow. The diluted share count fell 0.4%.
About these figures. Share counts and per-share figures for earlier years are restated for a stock split (2-for-1), so every year is on today's share basis.
What Hawkins does
No business description yet.
- Legal name
- HAWKINS, INC.
- Fiscal year ends
- March 29, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0000046250-26-000018
0000046250
Revenue and margins
Hawkins had $1.1B of revenue in fiscal 2026, up 11.2% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 15.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $86.1M in fiscal 2026, 7.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hawkins returned $15.7M to shareholders in fiscal 2026, 18% of free cash flow. The diluted share count fell 0.4%.
Value Hawkins yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$240M and divides by 20.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 34.3x Β· peers 29.2x Β· sector 20.1x.
Balance sheet
Cash, debt and the ratios that show how comfortably Hawkins can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $3.5M | $7.6M | $7.2M | $5.1M | $3.9M |
| Debt incl. finance leases | $126M | $112M | $98.7M | $149M | $244M |
| Net debt / EBITDA | 1.3x | 0.9x | 0.7x | 0.9x | 1.4x |
| Debt / equity | 0.4x | 0.3x | 0.2x | 0.3x | 0.5x |
| Interest coverage | 59.5x | 18.5x | 22.4x | 20.6x | 8.9x |
| Current ratio | 2.2x | 2.6x | 2.0x | 2.4x | 2.2x |
| Quick ratio | 1.3x | 1.6x | 1.2x | 1.5x | 1.5x |
| Total assets | $567M | $591M | $658M | $770M | $986M |
| Total liabilities | $265M | $241M | $252M | $310M | $452M |
| Shareholders' equity | $303M | $350M | $406M | $460M | $534M |
| Net debt (β = net cash) | $122M | $104M | $91.5M | $144M | $240M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.9M
4 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Jeffrey P. OldenkampExecutive VP and CFO | Bought | 1,290 | $119.00 | $0.2M | Form 4 |
| Aug 25, 2026 | Douglas A. LangeVP - Water Treatment Group | Bought | 910 | $118.75 | $0.1M | Form 4 |
| Feb 5, 2026 | James A FaulconbridgeDirector | Bought | 1,500 | $129.95 | $0.2M | Form 4 |
| Feb 4, 2026 | James A FaulconbridgeDirector | Bought | 1,500 | $129.29 | $0.2M | Form 4 |
| Nov 3, 2025 | Drew M. GrahekVice President of Operations | Bought | 1,587 | $126.34 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 7 / 9 | 4 / 9 |
| Accruals ratio | β13.5% | β3.8% | β7.2% |
| Altman Z'' | 5.55 | 5.58 | 4.56 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Hawkins HWKN | $2.8B | 11.2% | 11.2% | 7.9% | 13.1% | 34.3x | 4 | |
| Koppers KOP | $767M | β10.2% | 8.9% | 3.6% | 8.1% | β | 8 | Compare β |
| Dow DOW | $23.5B | β7.0% | β | β3.6% | β4.1% | β | 3 | Compare β |
| Balchem BCPC | $5.7B | 8.8% | 20.2% | 16.7% | β | 33.3x | β | Compare β |
| Royal Gold RGLD | $19.4B | 43.2% | 61.9% | β | 9.7% | 25.2x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $484M | $504M | $556M | $540M | $597M | $775M | $935M | $919M | $974M | $1.1B |
| Gross profit | $98.1M | $86.8M | $95.9M | $101M | $124M | $147M | $165M | $194M | $226M | $245M |
| Operating income | $38.7M | β$11.8M | $36.8M | $41.7M | $55.9M | $71.2M | $88.1M | $104M | $119M | $121M |
| Interest expense | $2.3M | $3.0M | $3.2M | $2.4M | $1.3M | $1.2M | $4.8M | $4.7M | $5.8M | $13.6M |
| Pretax income | $36.0M | β$15.1M | $33.5M | $39.0M | $55.9M | $70.0M | $82.6M | $101M | $114M | $109M |
| Income tax | $13.5M | β$5.9M | $9.1M | $10.6M | $14.9M | $18.4M | $22.5M | $25.8M | $30.0M | $27.8M |
| Net income | $22.6M | β$9.2M | $24.4M | $28.4M | $41.0M | $51.5M | $60.0M | $75.4M | $84.3M | $81.5M |
| Diluted EPS | $1.06 | β$0.43 | $1.14 | $1.33 | $1.93 | $2.44 | $2.86 | $3.59 | $4.03 | $3.91 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $44.9M | $27.3M | $48.0M | $58.9M | $43.8M | $42.8M | $77.4M | $160M | $111M | $144M |
| Capital expenditure | $21.6M | $19.7M | $12.6M | $24.5M | $20.8M | $28.5M | $48.3M | $40.2M | $41.1M | $58.2M |
| Free cash flow | $23.2M | $7.7M | $35.4M | $34.4M | $23.0M | $14.3M | $29.1M | $119M | $70.0M | $86.1M |
| Depreciation and amortization | $20.9M | $22.4M | $21.8M | $21.6M | $22.7M | $24.1M | $27.4M | $31.8M | $39.9M | $52.5M |
| Stock-based compensation | $2.1M | $1.4M | $2.0M | $2.3M | $3.3M | $3.8M | $3.8M | $4.9M | $6.5M | $8.6M |
| Acquisitions | $2.2M | $0.0M | $0.0M | $0.0M | $51.0M | $21.5M | $0.0M | $83.5M | $87.4M | $167M |
| Share buybacks | $0.0M | $0.0M | $4.4M | $5.9M | $4.1M | $8.5M | $6.6M | $11.3M | $20.7M | $0.0M |
| Dividends paid | $8.7M | $9.2M | $12.0M | $9.8M | $10.0M | $11.1M | $12.0M | $13.2M | $14.6M | $15.7M |
| Dividends and buybacks | $8.7M | $9.2M | $16.3M | $15.7M | $14.2M | $19.6M | $18.6M | $24.5M | $35.3M | $15.7M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $6.9M | $5.0M | $9.2M | $4.3M | $3.0M | $3.5M | $7.6M | $7.2M | $5.1M | $3.9M |
| Total debt | $103M | $101M | $85.0M | $59.7M | $98.8M | $126M | $112M | $98.7M | $149M | $244M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $121M | $135M | $139M | $131M | $163M | $228M | $232M | $203M | $231M | $232M |
| Current liabilities | $55.7M | $60.6M | $55.4M | $62.2M | $70.5M | $102M | $90.9M | $103M | $97.2M | $105M |
| Inventory | $51.2M | $59.7M | $60.5M | $54.4M | $63.9M | $95.0M | $88.8M | $74.6M | $83.5M | $78.2M |
| Property and equipment, net | $122M | $124M | $119M | $126M | $145M | $162M | $186M | $209M | $225M | $266M |
| Total assets | $419M | $391M | $386M | $389M | $473M | $567M | $591M | $658M | $770M | $986M |
| Total liabilities | $201M | $189M | $168M | $156M | $207M | $265M | $241M | $252M | $310M | $452M |
| Shareholders' equity | $218M | $202M | $218M | $234M | $265M | $303M | $350M | $406M | $460M | $534M |
| Margins | ||||||||||
| Gross margin | 20.3% | 17.2% | 17.2% | 18.7% | 20.7% | 18.9% | 17.7% | 21.1% | 23.2% | 22.6% |
| Operating margin | 8.0% | β2.3% | 6.6% | 7.7% | 9.4% | 9.2% | 9.4% | 11.3% | 12.2% | 11.2% |
| EBITDA margin | 12.3% | 2.1% | 10.5% | 11.7% | 13.2% | 12.3% | 12.4% | 14.8% | 16.3% | 16.0% |
| Net margin | 4.7% | β1.8% | 4.4% | 5.3% | 6.9% | 6.7% | 6.4% | 8.2% | 8.7% | 7.5% |
| FCF margin | 4.8% | 1.5% | 6.4% | 6.4% | 3.9% | 1.9% | 3.1% | 13.0% | 7.2% | 7.9% |
| Returns | ||||||||||
| Return on capital | 7.8% | β3.0% | 9.1% | 10.4% | 12.6% | 13.4% | 14.6% | 16.3% | 16.0% | 13.1% |
| Return on capital employed | 10.5% | β3.4% | 11.2% | 12.7% | 15.3% | 16.4% | 18.3% | 19.7% | 19.4% | 15.6% |
| Return on equity | 10.8% | β4.4% | 11.6% | 12.6% | 16.4% | 18.2% | 18.4% | 19.9% | 19.5% | 16.4% |
| Return on assets | 5.3% | β2.3% | 6.3% | 7.3% | 9.5% | 9.9% | 10.4% | 12.1% | 11.8% | 9.3% |
| Growth | ||||||||||
| Revenue growth | 16.8% | 4.3% | 10.4% | β2.9% | 10.5% | 29.8% | 20.7% | β1.7% | 6.0% | 11.2% |
| Net income growth | 24.3% | β140.7% | β | 16.1% | 44.5% | 25.8% | 16.5% | 25.5% | 11.9% | β3.3% |
| EPS growth | 23.8% | β140.4% | β | 16.7% | 45.1% | 26.4% | 17.2% | 25.5% | 12.3% | β3.0% |
| FCF growth | 91.3% | β67.1% | 362.6% | β2.9% | β33.1% | β37.7% | 103.0% | 310.4% | β41.4% | 23.0% |
| Share count change | 0.2% | 0.5% | 0.8% | β0.7% | β0.2% | β0.6% | β0.6% | 0.0% | β0.4% | β0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.6x | 9.0x | 1.3x | 0.9x | 1.2x | 1.3x | 0.9x | 0.7x | 0.9x | 1.4x |
| Debt / equity | 0.5x | 0.5x | 0.4x | 0.3x | 0.4x | 0.4x | 0.3x | 0.2x | 0.3x | 0.5x |
| Interest coverage | 16.5x | β3.9x | 11.7x | 17.3x | 43.4x | 59.5x | 18.5x | 22.4x | 20.6x | 8.9x |
| Current ratio | 2.2x | 2.2x | 2.5x | 2.1x | 2.3x | 2.2x | 2.6x | 2.0x | 2.4x | 2.2x |
| Quick ratio | 1.3x | 1.2x | 1.4x | 1.2x | 1.4x | 1.3x | 1.6x | 1.2x | 1.5x | 1.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.5% | 3.9% | 2.3% | 4.5% | 3.5% | 3.7% | 5.2% | 4.4% | 4.2% | 5.4% |
| Stock comp / revenue | 0.4% | 0.3% | 0.4% | 0.4% | 0.6% | 0.5% | 0.4% | 0.5% | 0.7% | 0.8% |
| Payouts / FCF | 37.4% | 119.8% | 46.2% | 45.6% | 61.6% | 136.8% | 63.8% | 20.5% | 50.4% | 18.2% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 4.0 | 8.0 | 7.0 | 8.0 | 5.0 | 7.0 | 7.0 | 7.0 | 4.0 |
| Altman Z'' | 4.1 | 3.4 | 4.8 | 5.0 | 4.9 | 5.0 | 5.8 | 5.6 | 5.6 | 4.6 |
| Accruals ratio | β5.2% | β9.0% | β6.1% | β7.9% | β0.7% | 1.7% | β3.0% | β13.5% | β3.8% | β7.2% |
Source: SEC EDGAR XBRL filings (CIK 0000046250). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.